4.3 Article

Protocatechuic acid as an inhibitor of the JNK/CXCL1/CXCR2 pathway relieves neuropathic pain in chronic constriction injury rats

Journal

BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES
Volume 22, Issue 2, Pages 217-228

Publisher

ASSOC BASIC MEDICAL SCI FEDERATION BOSNIA & HERZEGOVINA SARAJEVO
DOI: 10.17305/bjbms.2021.5928

Keywords

Chronic neuropathic pain; JNK/CXCL1/chemokine receptor 2 signaling pathway; protocatechuic acid; tumor necrosis factor-alpha

Ask authors/readers for more resources

Emerging evidence suggests that protocatechuic acid (PCA) has antioxidant and anti-inflammatory effects, and can alleviate neuropathic pain in rats. The mechanism of action may be through inhibiting the JNK/CXCL1/CXCR2 signaling pathway and improving oxidative stress. These findings provide a novel perspective for the treatment of neuropathic pain caused by chronic constriction injury (CCI).
Emerging evidence has shown that protocatechuic acid (PCA) has antioxidant and anti-inflammatory effects. Evidence suggests that PCA can alleviate the injury of sciatic nerve, while the mechanism of its therapeutic effect on neuralgia remains unknown. Chromium bowel ligation was used in vivo to establish a chronic constriction injury (CCI) rat model to induce sciatic nerve pain. Subsequently, two doses of PCA were used to treat CCI rats. In vitro, 10 ng/mL tumor necrosis factor-alpha (TNF-alpha) was used to stimulate glial satellite cells derived from the dorsal root ganglia (DRG) L-4-L-6 of the sciatic nerve to simulate sciatic nerve pain. PCA relieved mechanical allodynia and thermal hyperalgesia in CCI rats. CCK-8 assay revealed that PCA inhibited the proliferation of glial satellite cells induced by TNF-alpha. Moreover, enzyme-linked immunosorbent assay demonstrated that PCA could improve the inflammatory response of rats caused by CCI and cells induced by TNF-alpha. Next, reverse transcription quantitative polymerase chain reaction and Western blot assays showed that PCA blocked the c-Jun N-terminal kinase/ the chemokine ligand 1/CXC chemokine receptor 2 (JNK/CXCL1/CXCR2) pathway by inhibiting CXCL1 levels in cells induced by TNF-alpha and DRG in CCI rats. In conclusion, PCA can alleviate neuropathic pain in CCI rats and improve oxidative stress by inhibiting the INK/CXCL1/CXCR2 signaling pathway Thus, these findings provide a new perspective for the treatment of neuropathic pain caused by CCI.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available